Assessment of plasma, vaginal fluid and tissue pharmacokinetic parameters
Briefly, a reversed-phase ultra-performance liquid chromatographic (UPLC), tandem mass spectrometry (MS/MS) assay for the determination of TFV and TAF was developed and validated for use with KApplication to vaginal fluid alternative matrix collected A reversed-phase high performance liquid chromatographic (HPLC), tandem MS/MS assay for the determination of EVG in human plasma was developed and validated for use with KSimilar to TAF and TFV, application to vaginal fluid alternative matrix collected 